Press release
HIV Drugs Market | Growth Trends, Opportunities And Forecast Period 2020-23 | Covid 19 Implications And Growth
The global HIV drugs market is expected to grow from $27 billion in 2019 to about $30.5 billion in 2020 due to an increase in demand for such drugs for the treatment of Covid-19 patients. The market is expected to stabilize and reach $34.2 billion at a CAGR of 5.9% through 2023.
Place a DIRECT PURCHASE ORDER of The Entire 140+ Pages Report @
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2834
The HIV drugs market consists of sales of Human Immunodeficiency Virus (HIV) drugs used for the treatment of HIV infection/AIDS. The market consists of revenue generated by the antiretroviral drug companies manufacturing the anti-retroviral drugs such as nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), entry and fusion inhibitors, integrase inhibitors, and protease inhibitors (PIs) for the treatment of HIV infection.
Increasing awareness among people regarding diagnosis and treatment of HIV disease acts as an important driver for the growth of the HIV drug market. HIV/AIDS is one of the most chronic diseases and the high prevalence of the disease in almost all parts of the world has resulted in an unprecedented awareness regarding the disease.
HIV Drugs Market Segmentation: -
By Type
1. Nucleoside Reverse Transcriptase Inhibitors (NRT’s)
2. Non- Nucleoside Reverse Transcriptase Inhibitors (NNRT’s)
3. Protease Inhibitors
4. Integrate Inhibitors
5. Fusion Inhibitors
Browse Complete Report @
https://www.thebusinessresearchcompany.com/report/hiv-drugs-market-global-report-2020-2030-covid-19-implications-and-growth
Few Points From Table Of Content
1. Executive Summary
2. HIV Drugs Market Characteristics
3. HIV Drugs Market Size And Growth
4. HIV Drugs Market Segmentation
5. HIV Drugs Market Regional And Country Analysis
……………
25. HIV Drugs Market Competitive Landscape And Company Profiles
26. Key Mergers And Acquisitions In The HIV Drugs Market
27. HIV Drugs Market Trends And Strategies
28. HIV Drugs Market Future Outlook and Potential Analysis
29. Appendix
The report covers the trends and market dynamics of the HIV drugs market in major countries - Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The report also includes consumer surveys and various future opportunities for the market.
Request for a Sample Copy of This Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=2834&type=smp
Some of the key players involved in the HIV drugs market are ViiV Healthcare, Gilead Sciences, Merck & Co., Inc., Bristol-Myers Squibb Company, Janssen (Johnson & Johnson), F. HOFFMANN-LA ROCHE LTD, Boehringer Ingelheim (C.H. Boehringer Sohn AG & Ko. KG), AbbVie, Inc., GlaxoSmithKline plc, Mylan Pharmaceuticals
Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on Blog: http://blog.tbrc.info/
About Us:
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets after WHO declared COVID-19 as a pandemic.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release HIV Drugs Market | Growth Trends, Opportunities And Forecast Period 2020-23 | Covid 19 Implications And Growth here
News-ID: 2074412 • Views: …
More Releases from The Business research company
Brick Making Machines Market 2024-2033: Growth Trends, Forecast & Competitive La …
The brick making machines market size has grown strongly in recent years. It will grow from $2.09 billion in 2023 to $2.2 billion in 2024 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to urbanization, expansion of construction and infrastructure projects, growth of the real estate and housing sector, increased demand for durable and cost-effective construction materials, population…
Private Tutoring Market 2024-2033: Size, Share & Competitive Landscape Analysis
The private tutoring market size has grown strongly in recent years. It will grow from $110.96 billion in 2023 to $120.88 billion in 2024 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to academic pressure, government policies and funding, shift in parenting styles, growing middle-class families, cultural emphasis on education, urbanization and busy lifestyles.
The private tutoring …
RNA Targeting Small Molecule Drug Discovery Market 2024-2033: Trends, Analysis & …
The rna targeting small molecule drug discovery market size has grown exponentially in recent years. It will grow from $1.45 billion in 2023 to $1.78 billion in 2024 at a compound annual growth rate (CAGR) of 22.3%. The growth in the historic period can be attributed to increased understanding of disease genetics, genomic and proteomic discoveries, drug resistance challenges, investment in biotechnology and pharmaceutical research, rise of…
Contract Furniture Market 2024-2033: Trends, Analysis & Growth Forecast
The contract furniture market size has grown strongly in recent years. It will grow from $59.81 billion in 2023 to $63.61 billion in 2024 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to corporate office expansion, trends in office design, hospitality and tourism growth, sustainable and eco-friendly practices, globalization of business.
The contract furniture market size is expected to…
More Releases for HIV
HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is …
HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully elucidated, some research evidence reported that it occurs in HIV-infected patients who are under antiretroviral medications. According to an article published in National Center for Biotechnology Information (NCBI) in 2014, prevalence of…
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication…
HIV Therapeutics Market– South Africa's Aspen launches three-in-one HIV drug
Recent Developments
Aspen Pharma care, a South Africa’s drug maker has launched a triple combination of tablet for the treatment of HIV in the country where the HIV virus is the most prevalent. The company's new Emdolten drug is a once a day tablet which is in the form of dolutegravir, an antiretroviral medication that balances the drug’s resistance. The company has launched Aspen Stavudine which was its first generic ARV…
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Introduction to Human Immunodeficiency Virus (HIV) Vaccines
1.1 Overview
1.2 Antiquity of HIV Vaccine
Need for the Development of HIV Vaccine
Primer of HIV inside the Body
3.1 Inclusion of HIV Virus into the System
3.2 Interaction of HIV with Host
3.3 Eradication of HIV Virus
HIV Vaccine Development Process
4.1 Introduction
…
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways…
Hidden HIV Revealed: New Insights Into Latent HIV Infections
In spite of ever more effective therapies, HIV keeps managing to survive in the body. A comprehensive project conducted by the Austrian Science Fund FWF has clarified the molecular processes which contribute to this effect. In the process, approaches were discovered for possible therapies to combat the hidden reservoir formed by the virus.
Thanks to modern therapies, HIV infections have become controllable – but these treatments cannot provide a cure. Antiretroviral…
